Access to Medicine Versus Test Data Exclusivity Safeguarding Flexibilities Under International Law /
| 主要作者: | |
|---|---|
| 企业作者: | |
| 总结: | XVI, 256 p. 78 illus., 56 illus. in color. text |
| 语言: | 英语 |
| 出版: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2016.
|
| 版: | 1st ed. 2016. |
| 丛编: | Munich Studies on Innovation and Competition,
4 |
| 主题: | |
| 在线阅读: | https://doi.org/10.1007/978-3-662-49655-8 |
| 格式: | 电子 电子书 |
书本目录:
- Introduction
- Test Data Exclusivity: Raison d'être
- Test Data Exclusivity and Art 39(3) TRIPS
- Test Data Exclusivity in the US and the EU
- Index of Data Exclusivity and Access (IDEAS) - Free Trade Agreements
- Index of Data Exclusivity and Access (IDEAS) - National Laws
- Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals
- Conclusions and Recommendations.